ELISAs (Enzyme-linked immunosorbent assays) are routinely used for the qualitative and quantitative assessment of cytokines, chemokines, growth factors, phosphorylated targets, immunoglobulins and other immunological markers. Detection and quantitation of protein analytes from various biological samples—serum, plasma, cell culture supernatants and cell lysates—indicate a multitude of biological and pathological events. ELISAs have proven to be valuable tools in drug development as they are commonly used for biomarker profiling of disease vs. normal states, as well as toxicity profiling.
The global Enzyme-Linked Immunosorbent Assay (Elisa) Testing market was valued at US$ 179 million in 2023 and is anticipated to reach US$ 230.5 million by 2030, witnessing a CAGR of 3.6% during the forecast period 2024-2030.
Global Enzyme-Linked Immunosorbent Assay (ELISA) key players include R&D Systems, Thermo Fisher Scientific, Ortho Clinical Diagnostics, BD Biosciences, etc. Global top four manufacturers hold a share over 45%.
China is the largest market, with a share over 35%, followed by Europe, and USA, both have a share over 30 percent.
In terms of product, Indirect ELISA is the largest segment, with a share over 45%. And in terms of application, the largest application is Immunology, followed by Infectious Diseases, Protein Quantitation, Cancer, etc.
This report aims to provide a comprehensive presentation of the global market for Enzyme-Linked Immunosorbent Assay (Elisa) Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enzyme-Linked Immunosorbent Assay (Elisa) Testing.
Report Scope
The Enzyme-Linked Immunosorbent Assay (Elisa) Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Enzyme-Linked Immunosorbent Assay (Elisa) Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Enzyme-Linked Immunosorbent Assay (Elisa) Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Ortho-Clinical Diagnostics, Inc.
Thermo Fisher Scientific. Inc.
Life Technologies Corporation
ZEUS Scientific, Inc.
R & D Systems (a Biotechne brand)
Abbexa
Abcam
Abelisa
Abnova
Bhat Bio-tech
Bio-Rad Laboratories
Biorbyt
Calbiotech
Cayman Chemicals
Crystal Chem
Diagenics
Eagle Biosciences
Segment by Type
Sandwich ELISA
Indirect ELISA
Multiple and portable ELISA
Competitive ELISA
Segment by Application
Immunology
Inflammation
Infectious diseases
Cancer
Protein quantitation
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Enzyme-Linked Immunosorbent Assay (Elisa) Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Sandwich ELISA
1.2.3 Indirect ELISA
1.2.4 Multiple and portable ELISA
1.2.5 Competitive ELISA
1.3 Market by Application
1.3.1 Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Immunology
1.3.3 Inflammation
1.3.4 Infectious diseases
1.3.5 Cancer
1.3.6 Protein quantitation
1.3.7 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market Perspective (2019-2030)
2.2 Enzyme-Linked Immunosorbent Assay (Elisa) Testing Growth Trends by Region
2.2.1 Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Enzyme-Linked Immunosorbent Assay (Elisa) Testing Historic Market Size by Region (2019-2024)
2.2.3 Enzyme-Linked Immunosorbent Assay (Elisa) Testing Forecasted Market Size by Region (2025-2030)
2.3 Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market Dynamics
2.3.1 Enzyme-Linked Immunosorbent Assay (Elisa) Testing Industry Trends
2.3.2 Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market Drivers
2.3.3 Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market Challenges
2.3.4 Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Enzyme-Linked Immunosorbent Assay (Elisa) Testing Players by Revenue
3.1.1 Global Top Enzyme-Linked Immunosorbent Assay (Elisa) Testing Players by Revenue (2019-2024)
3.1.2 Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Revenue Market Share by Players (2019-2024)
3.2 Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Enzyme-Linked Immunosorbent Assay (Elisa) Testing Revenue
3.4 Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market Concentration Ratio
3.4.1 Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Enzyme-Linked Immunosorbent Assay (Elisa) Testing Revenue in 2023
3.5 Enzyme-Linked Immunosorbent Assay (Elisa) Testing Key Players Head office and Area Served
3.6 Key Players Enzyme-Linked Immunosorbent Assay (Elisa) Testing Product Solution and Service
3.7 Date of Enter into Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Enzyme-Linked Immunosorbent Assay (Elisa) Testing Breakdown Data by Type
4.1 Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Historic Market Size by Type (2019-2024)
4.2 Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Forecasted Market Size by Type (2025-2030)
5 Enzyme-Linked Immunosorbent Assay (Elisa) Testing Breakdown Data by Application
5.1 Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Historic Market Size by Application (2019-2024)
5.2 Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market Size (2019-2030)
6.2 North America Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market Size by Country (2019-2024)
6.4 North America Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market Size (2019-2030)
7.2 Europe Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market Size by Country (2019-2024)
7.4 Europe Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market Size (2019-2030)
8.2 Asia-Pacific Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market Size (2019-2030)
9.2 Latin America Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market Size by Country (2019-2024)
9.4 Latin America Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market Size (2019-2030)
10.2 Middle East & Africa Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Ortho-Clinical Diagnostics, Inc.
11.1.1 Ortho-Clinical Diagnostics, Inc. Company Detail
11.1.2 Ortho-Clinical Diagnostics, Inc. Business Overview
11.1.3 Ortho-Clinical Diagnostics, Inc. Enzyme-Linked Immunosorbent Assay (Elisa) Testing Introduction
11.1.4 Ortho-Clinical Diagnostics, Inc. Revenue in Enzyme-Linked Immunosorbent Assay (Elisa) Testing Business (2019-2024)
11.1.5 Ortho-Clinical Diagnostics, Inc. Recent Development
11.2 Thermo Fisher Scientific. Inc.
11.2.1 Thermo Fisher Scientific. Inc. Company Detail
11.2.2 Thermo Fisher Scientific. Inc. Business Overview
11.2.3 Thermo Fisher Scientific. Inc. Enzyme-Linked Immunosorbent Assay (Elisa) Testing Introduction
11.2.4 Thermo Fisher Scientific. Inc. Revenue in Enzyme-Linked Immunosorbent Assay (Elisa) Testing Business (2019-2024)
11.2.5 Thermo Fisher Scientific. Inc. Recent Development
11.3 Life Technologies Corporation
11.3.1 Life Technologies Corporation Company Detail
11.3.2 Life Technologies Corporation Business Overview
11.3.3 Life Technologies Corporation Enzyme-Linked Immunosorbent Assay (Elisa) Testing Introduction
11.3.4 Life Technologies Corporation Revenue in Enzyme-Linked Immunosorbent Assay (Elisa) Testing Business (2019-2024)
11.3.5 Life Technologies Corporation Recent Development
11.4 ZEUS Scientific, Inc.
11.4.1 ZEUS Scientific, Inc. Company Detail
11.4.2 ZEUS Scientific, Inc. Business Overview
11.4.3 ZEUS Scientific, Inc. Enzyme-Linked Immunosorbent Assay (Elisa) Testing Introduction
11.4.4 ZEUS Scientific, Inc. Revenue in Enzyme-Linked Immunosorbent Assay (Elisa) Testing Business (2019-2024)
11.4.5 ZEUS Scientific, Inc. Recent Development
11.5 R & D Systems (a Biotechne brand)
11.5.1 R & D Systems (a Biotechne brand) Company Detail
11.5.2 R & D Systems (a Biotechne brand) Business Overview
11.5.3 R & D Systems (a Biotechne brand) Enzyme-Linked Immunosorbent Assay (Elisa) Testing Introduction
11.5.4 R & D Systems (a Biotechne brand) Revenue in Enzyme-Linked Immunosorbent Assay (Elisa) Testing Business (2019-2024)
11.5.5 R & D Systems (a Biotechne brand) Recent Development
11.6 Abbexa
11.6.1 Abbexa Company Detail
11.6.2 Abbexa Business Overview
11.6.3 Abbexa Enzyme-Linked Immunosorbent Assay (Elisa) Testing Introduction
11.6.4 Abbexa Revenue in Enzyme-Linked Immunosorbent Assay (Elisa) Testing Business (2019-2024)
11.6.5 Abbexa Recent Development
11.7 Abcam
11.7.1 Abcam Company Detail
11.7.2 Abcam Business Overview
11.7.3 Abcam Enzyme-Linked Immunosorbent Assay (Elisa) Testing Introduction
11.7.4 Abcam Revenue in Enzyme-Linked Immunosorbent Assay (Elisa) Testing Business (2019-2024)
11.7.5 Abcam Recent Development
11.8 Abelisa
11.8.1 Abelisa Company Detail
11.8.2 Abelisa Business Overview
11.8.3 Abelisa Enzyme-Linked Immunosorbent Assay (Elisa) Testing Introduction
11.8.4 Abelisa Revenue in Enzyme-Linked Immunosorbent Assay (Elisa) Testing Business (2019-2024)
11.8.5 Abelisa Recent Development
11.9 Abnova
11.9.1 Abnova Company Detail
11.9.2 Abnova Business Overview
11.9.3 Abnova Enzyme-Linked Immunosorbent Assay (Elisa) Testing Introduction
11.9.4 Abnova Revenue in Enzyme-Linked Immunosorbent Assay (Elisa) Testing Business (2019-2024)
11.9.5 Abnova Recent Development
11.10 Bhat Bio-tech
11.10.1 Bhat Bio-tech Company Detail
11.10.2 Bhat Bio-tech Business Overview
11.10.3 Bhat Bio-tech Enzyme-Linked Immunosorbent Assay (Elisa) Testing Introduction
11.10.4 Bhat Bio-tech Revenue in Enzyme-Linked Immunosorbent Assay (Elisa) Testing Business (2019-2024)
11.10.5 Bhat Bio-tech Recent Development
11.11 Bio-Rad Laboratories
11.11.1 Bio-Rad Laboratories Company Detail
11.11.2 Bio-Rad Laboratories Business Overview
11.11.3 Bio-Rad Laboratories Enzyme-Linked Immunosorbent Assay (Elisa) Testing Introduction
11.11.4 Bio-Rad Laboratories Revenue in Enzyme-Linked Immunosorbent Assay (Elisa) Testing Business (2019-2024)
11.11.5 Bio-Rad Laboratories Recent Development
11.12 Biorbyt
11.12.1 Biorbyt Company Detail
11.12.2 Biorbyt Business Overview
11.12.3 Biorbyt Enzyme-Linked Immunosorbent Assay (Elisa) Testing Introduction
11.12.4 Biorbyt Revenue in Enzyme-Linked Immunosorbent Assay (Elisa) Testing Business (2019-2024)
11.12.5 Biorbyt Recent Development
11.13 Calbiotech
11.13.1 Calbiotech Company Detail
11.13.2 Calbiotech Business Overview
11.13.3 Calbiotech Enzyme-Linked Immunosorbent Assay (Elisa) Testing Introduction
11.13.4 Calbiotech Revenue in Enzyme-Linked Immunosorbent Assay (Elisa) Testing Business (2019-2024)
11.13.5 Calbiotech Recent Development
11.14 Cayman Chemicals
11.14.1 Cayman Chemicals Company Detail
11.14.2 Cayman Chemicals Business Overview
11.14.3 Cayman Chemicals Enzyme-Linked Immunosorbent Assay (Elisa) Testing Introduction
11.14.4 Cayman Chemicals Revenue in Enzyme-Linked Immunosorbent Assay (Elisa) Testing Business (2019-2024)
11.14.5 Cayman Chemicals Recent Development
11.15 Crystal Chem
11.15.1 Crystal Chem Company Detail
11.15.2 Crystal Chem Business Overview
11.15.3 Crystal Chem Enzyme-Linked Immunosorbent Assay (Elisa) Testing Introduction
11.15.4 Crystal Chem Revenue in Enzyme-Linked Immunosorbent Assay (Elisa) Testing Business (2019-2024)
11.15.5 Crystal Chem Recent Development
11.16 Diagenics
11.16.1 Diagenics Company Detail
11.16.2 Diagenics Business Overview
11.16.3 Diagenics Enzyme-Linked Immunosorbent Assay (Elisa) Testing Introduction
11.16.4 Diagenics Revenue in Enzyme-Linked Immunosorbent Assay (Elisa) Testing Business (2019-2024)
11.16.5 Diagenics Recent Development
11.17 Eagle Biosciences
11.17.1 Eagle Biosciences Company Detail
11.17.2 Eagle Biosciences Business Overview
11.17.3 Eagle Biosciences Enzyme-Linked Immunosorbent Assay (Elisa) Testing Introduction
11.17.4 Eagle Biosciences Revenue in Enzyme-Linked Immunosorbent Assay (Elisa) Testing Business (2019-2024)
11.17.5 Eagle Biosciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Ortho-Clinical Diagnostics, Inc.
Thermo Fisher Scientific. Inc.
Life Technologies Corporation
ZEUS Scientific, Inc.
R & D Systems (a Biotechne brand)
Abbexa
Abcam
Abelisa
Abnova
Bhat Bio-tech
Bio-Rad Laboratories
Biorbyt
Calbiotech
Cayman Chemicals
Crystal Chem
Diagenics
Eagle Biosciences
Ěý
Ěý
*If Applicable.
